These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35892971)

  • 1. The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma.
    Huang K; Wang H; Xu J; Xu R; Liu Z; Li Y; Xu Z
    Biology (Basel); 2022 Jul; 11(8):. PubMed ID: 35892971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of TPM1-4 in hepatocellular carcinoma.
    Tian Z; Zhao J; Wang Y
    Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer.
    Yan Y; Li J; Ye M; Li Z; Li S
    Dis Markers; 2022; 2022():6936262. PubMed ID: 35734544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma.
    Huang K; Xu H; Han L; Xu R; Xu Z; Xie Y
    Front Mol Biosci; 2022; 9():1054614. PubMed ID: 36699699
    [No Abstract]   [Full Text] [Related]  

  • 5. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
    Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
    Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma.
    Li Y; Zhang Y; Wu Z; Sun P
    BMC Neurol; 2023 Jan; 23(1):17. PubMed ID: 36639743
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Xu L; Liu Z; Wang H; Lu J; Xu J; Meng Y; Huang K; Liu B
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas.
    Tao T; Shi Y; Han D; Luan W; Qian J; Zhang J; Wang Y; You Y;
    Tumour Biol; 2014 Sep; 35(9):9053-9. PubMed ID: 24913705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma.
    Zhang F; Cai HB; Liu HZ; Gao S; Wang B; Hu YC; Cheng HW; Liu JX; Gao Y; Hong WM
    Dis Markers; 2022; 2022():8133505. PubMed ID: 35493303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle type specific expression of tropomyosin isoforms in bovine skeletal muscles.
    Oe M; Ohnishi-Kameyama M; Nakajima I; Muroya S; Chikuni K
    Meat Sci; 2007 Apr; 75(4):558-63. PubMed ID: 22064019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between tropomyosin and myosin heavy chain isoforms in bovine skeletal muscle.
    Oe M; Nakajima I; Muroya S; Shibata M; Chikuni K
    Anim Sci J; 2009 Apr; 80(2):193-7. PubMed ID: 20163590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of beta-tropomyosin (Tpm2) and duplication of the alpha-slow tropomyosin gene (TPM3) in Atlantic salmon Salmo salar.
    Silva AMM; Kennedy LS; Hasan SC; Cohen AM; Heeley DH
    Comp Biochem Physiol B Biochem Mol Biol; 2020 Jul; 245():110439. PubMed ID: 32283206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomeric TPM3 expression in human heart and skeletal muscle.
    Dube DK; Dube S; Abbott L; Elsekaily O; Sanger JW; Sanger JM; Poiesz BJ
    Cytoskeleton (Hoboken); 2020 Aug; 77(8):313-328. PubMed ID: 32761805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity.
    Gong Y; Ke Y; Yu Z; Pan J; Zhou X; Jiang Y; Zhou M; Zeng H; Geng X; Hu G
    Aging (Albany NY); 2023 Aug; 15(16):8155-8184. PubMed ID: 37602882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
    Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma.
    Yuan Y; Yang B; Qi Z; Han Z; Cai J; Song J
    Front Oncol; 2022; 12():783721. PubMed ID: 35814367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.